Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 6/20 | 0.49 |
| ▸ | ITGAV | P06756 | 6/20 | 0.49 |
| ▸ | THRA | P10827 | 3/20 | 0.49 |
| ▸ | THRB | P10828 | 3/20 | 0.49 |
| ▸ | PPARG | P37231 | 3/20 | 0.49 |
| ▸ | RXRA | P19793 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | PCNA | P12004 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25718400 | 0.83 | ITGB3 (0.55) | ITGB3ITGAVTHRATHRBPPARG | |
| SCHEMBL25819215 | 0.83 | ITGB3 (0.58) | ITGB3ITGAVTHRATHRBPPARG | |
| SCHEMBL25718383 | 0.76 | THRB (0.56) | ITGB3ITGAVTHRATHRBPPARG | |
| SCHEMBL25819195 | 0.75 | THRB (0.65) | ITGB3ITGAVTHRATHRBPPARG | |
| SCHEMBL25819198 | 0.75 | THRB (0.55) | ITGB3ITGAVTHRATHRBPPARG | |
| SCHEMBL25819213 | 0.74 | THRB (0.70) | ITGB3ITGAVTHRATHRBPPARG | |
| SCHEMBL25819214 | 0.74 | THRB (0.70) | ITGB3ITGAVTHRATHRBPPARG | |
| SCHEMBL4273195 | 0.73 | FFAR1 (0.54) | ITGB3ITGAVTHRATHRBPPARG | |
| SCHEMBL8839147 | 0.73 | KMT2A (0.73) | LMNAHPGDSMN1; SMN2KMT2ASLC6A2 | |
| SCHEMBL12764500 | 0.72 | THRB (0.68) | ITGB3ITGAVTHRATHRBPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11723888-B2 | Polymer conjugated thyrointegrin antagonists | NANOPHARMACEUTICALS LLC (US) | 2023-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11723888-B2 | Polymer conjugated thyrointegrin antagonists | TEK, HDGF, PTGFR | ITGB3 284/4885ITGAV 381/4885THRA 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.